◆ Polskie Archiwum Medycyny Wewnętrznej2026-05-04· Medicine
Interstitial lung abnormalities progression upon treatment with cabazitaxel for metastatic prostate cancer
Martyna Pniaczek, Stanisław Boznański, Natalia Kowalska, Emil Szmalec, Aleksandra Wojnarska, Krzysztof Sładek
原始摘要（英文原文）· Original abstract
A 75-year-old patient, a never-smoker, was treated for metastatic prostate cancer.Since 2018, he has subsequently undergone therapy with docetaxel, abiraterone, and olaparib.Due to bone metastasis, radiotherapy with Ra223 was performed.Since June 2025, 6 cycles of palliative